Literature DB >> 32875331

An Adapted Chronic Constriction Injury of the Sciatic Nerve Produces Sensory, Affective, and Cognitive Impairments: A Peripheral Mononeuropathy Model for the Study of Comorbid Neuropsychiatric Disorders Associated with Neuropathic Pain in Rats.

Priscila Medeiros1,2,3, Ieda Regina Dos Santos2, Ivair Matias Júnior4, Enza Palazzo5, José Aparecido da Silva2,6,7, Hélio Rubens Machado1,4, Sérgio Henrique Ferreira1,8, Sabatino Maione5,9, Norberto Cysne Coimbra1,2,3, Renato Leonardo de Freitas1,2,6,8.   

Abstract

BACKGROUND: Chronic constriction injury (CCI) is a model of neuropathic pain induced by four loose ligatures around the sciatic nerve. This work aimed to investigate the sensory, affective, cognitive, and motor changes induced by an adaptation of the CCI model by applying a single ligature around the sciatic nerve.
METHODS: Mechanical allodynia was measured from day 1 to day 28 postsurgery by the von Frey test. The beam walking test (BWT) was conducted weekly until 28 days after surgery. Anxiety- and depression-like behaviors, and cognitive performance were assessed through the open field (OF), forced swimming (FS), and novel object recognition (NOR) tests, respectively, 21 days after surgery.
RESULTS: The two CCI models, both Bennett and Xie's model (four ligatures of the sciatic nerve) and a modification of it (one ligature), induced mechanical allodynia, increased immobility in the FS, and reduced recognition index in the NOR. The exploratory behavior and time spent in the central part of the arena decreased, while the defensive behavior increased in the OF. The animals subjected to the two CCI models showed motor alterations in the BWT; however, autotomy was observed only in the group with four ligatures and not in the group with a single ligature.
CONCLUSIONS: Overall these results demonstrate that our adapted CCI model, using a single ligature around the sciatic nerve, induces sensory, affective, cognitive, and motor alterations comparable to the CCI model with four ligatures without generating autotomy. This adaptation to the CCI model may therefore represent an appropriate and more easily performed model for inducing neuropathic pain and study underlying mechanisms and effective treatments.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Anxiety- and Depression-Like Behaviors; Chronic Constriction Injury; Cognitive Performance; Mechanical Allodynia; Motor Activity; Neuropathic Pain

Mesh:

Year:  2021        PMID: 32875331     DOI: 10.1093/pm/pnaa206

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  4 in total

1.  Habenula activation patterns in a preclinical model of neuropathic pain accompanied by depressive-like behaviour.

Authors:  Geiza Fernanda Antunes; Ana Carolina Pinheiro Campos; Danielle Varin de Assis; Flavia Venetucci Gouveia; Midiã Dias de Jesus Seno; Rosana Lima Pagano; Raquel Chacon Ruiz Martinez
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

Review 2.  Mechanistic Rationale and Clinical Efficacy of Hyperbaric Oxygen Therapy in Chronic Neuropathic Pain: An Evidence-Based Narrative Review.

Authors:  Simone Schiavo; Julian DeBacker; Carine Djaiani; Anuj Bhatia; Marina Englesakis; Rita Katznelson
Journal:  Pain Res Manag       Date:  2021-04-22       Impact factor: 3.037

3.  Anti-nociceptive effects of dual neuropeptide antagonist therapy in mouse model of neuropathic and inflammatory pain.

Authors:  Min Su Kim; Bo Yeon Kim; Allen Saghetlians; Xiang Zhang; Takuya Okida; So Yeon Kim
Journal:  Korean J Pain       Date:  2022-04-01

4.  Anti-nociceptive effect of black seed oil on an animal model of chronic constriction injury.

Authors:  Sayyed Alireza Talaei; Hamid Reza Banafshe; Alireza Moravveji; Mohammad Shabani; Shiva Shirazi Tehrani; Alireza Abed
Journal:  Res Pharm Sci       Date:  2022-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.